BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23353044)

  • 1. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.
    Eisenberg MS; Cheville JC; Thompson RH; Kaushik D; Lohse CM; Boorjian SA; Costello BA; Leibovich BC
    J Urol; 2013 Jul; 190(1):37-43. PubMed ID: 23353044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.
    Rodríguez-Covarrubias F; Castillejos-Molina R; Sotomayor M; Méndez-Probst CE; Gómez-Alvarado MO; Uribe-Uribe N; Gabilondo F; Feria-Bernal G
    Urol Int; 2010; 85(1):23-9. PubMed ID: 20693824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma in young and old patients--is there a difference?
    Thompson RH; Ordonez MA; Iasonos A; Secin FP; Guillonneau B; Russo P; Touijer K
    J Urol; 2008 Oct; 180(4):1262-6; discussion 1266. PubMed ID: 18707708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
    Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
    Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.
    Gonçalves PD; Srougi M; Dall'lio MF; Leite KR; Ortiz V; Hering F
    J Urol; 2004 Aug; 172(2):470-4. PubMed ID: 15247705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic renal cell carcinoma risk according to tumor size.
    Thompson RH; Hill JR; Babayev Y; Cronin A; Kaag M; Kundu S; Bernstein M; Coleman J; Dalbagni G; Touijer K; Russo P
    J Urol; 2009 Jul; 182(1):41-5. PubMed ID: 19450840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
    Lane BR; Campbell SC; Gill IS
    J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations.
    Qin C; Sun LJ; Cui L; Cao Q; Zhu J; Li P; Zhang GM; Mao X; Shao PF; Wang ML; Zhang ZD; Gu M; Zhang W; Yin CJ
    Asian J Androl; 2013 Jul; 15(4):550-7. PubMed ID: 23564046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lymph node dissection in renal cell carcinoma.
    Delacroix SE; Chapin BF; Wood CG
    Urol Clin North Am; 2011 Nov; 38(4):419-28, vi. PubMed ID: 22045173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.